Abrocitinib and Belzutifan: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Belzutifan
Abrocitinib
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed two medicines that can interact. Abrocitinib (Cibinqo) can slow down a liver enzyme (called CYP2C19) that normally helps clear belzutifan (Welireg) out of your body. When belzutifan is cleared more slowly, more of it can build up, and that can raise your chance of side effects.
The main things to watch for with belzutifan are low red blood cell counts (anemia), which can leave you feeling tired or short of breath, and low oxygen levels (hypoxia). The good news is your care team can manage this easily by watching your blood counts and oxygen and adjusting your belzutifan dose if needed. Keep taking both as prescribed and check in with your doctor or pharmacist.
Effect: Abrocitinib inhibits CYP2C19, the primary enzyme metabolizing belzutifan, potentially increasing belzutifan exposure (AUC) and the incidence/severity of dose-dependent adverse reactions. Belzutifan is an active drug (not a prodrug), so inhibition increases its effect.
- Direction: Increased belzutifan exposure and toxicity risk.
- Severity/Evidence: Major; theoretical/mechanistic.
- Onset: Unspecified.
- Monitoring: Anemia (CBC) and hypoxia (oxygen saturation).
- Management: Reduce belzutifan per label if needed: first reduction 80 mg once daily, second 40 mg once daily, third permanently discontinue.
What happens
Increased belzutifan exposure and an increased risk of belzutifan-related adverse reactions
Interaction Deep Dive
Taking belzutifan together with CYP2C19 inhibitors can raise belzutifan levels, potentially leading to a greater frequency and intensity of adverse reactions. When these agents are given together, watch for anemia and hypoxia and lower the belzutifan dose as needed (first reduction to 80 mg once daily; second reduction to 40 mg once daily; third reduction means permanent discontinuation)1.
Why it happens (mechanism)
Inhibition of CYP2C19-mediated metabolism of belzutifan
How to manage this interaction
You can keep taking both medicines as prescribed unless your care team tells you otherwise. Because abrocitinib can raise belzutifan levels, your team will typically manage this by watching you more closely and tailoring your belzutifan dose.
- Expect monitoring for anemia (blood counts) and low oxygen (hypoxia).
- Your belzutifan dose may be reduced in steps if side effects appear (80 mg daily, then 40 mg daily, and rarely stopped).
- Tell your team about new tiredness, unusual shortness of breath, dizziness, or pale skin.
Do not change or stop either medicine on your own. Raise any questions with your pharmacist or prescriber.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Abrocitinib and Belzutifan together?
Abrocitinib may raise belzutifan levels and side effects like anemia and low oxygen, so your care team may monitor you more closely and adjust the belzutifan dose. Keep taking both as prescribed and report new fatigue or shortness of breath. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Abrocitinib and Belzutifan interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Abrocitinib and Belzutifan interaction managed?
You can keep taking both medicines as prescribed unless your care team tells you otherwise. Because abrocitinib can raise belzutifan levels, your team will typically manage this by watching you more closely and tailoring your belzutifan dose. Expect monitoring for anemia (blood counts) and low oxygen (hypoxia). Your belzutifan dose may be reduced in steps if side effects appear (80 mg daily, then… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Abrocitinib or Belzutifan need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: WELIREG(R) oral tablets, belzutifan oral tablets. Merck Sharp & Dohme LLC (per manufacturer), Rahway, NJ, 2025. DailyMed
Keep reading about Belzutifan
Keep reading about Abrocitinib
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist